nodes	percent_of_prediction	percent_of_DWPC	metapath
Methohexital—Anaphylactic shock—Vincristine—hematologic cancer	0.0011	0.0011	CcSEcCtD
Methohexital—Nausea—Procarbazine—hematologic cancer	0.00109	0.0011	CcSEcCtD
Methohexital—Gastrointestinal pain—Bortezomib—hematologic cancer	0.00109	0.00109	CcSEcCtD
Methohexital—Thrombophlebitis—Doxorubicin—hematologic cancer	0.00109	0.00109	CcSEcCtD
Methohexital—Vomiting—Chlorambucil—hematologic cancer	0.00108	0.00109	CcSEcCtD
Methohexital—Erythema—Prednisolone—hematologic cancer	0.00108	0.00108	CcSEcCtD
Methohexital—Hypotension—Carmustine—hematologic cancer	0.00108	0.00108	CcSEcCtD
Methohexital—Nausea—Bexarotene—hematologic cancer	0.00107	0.00107	CcSEcCtD
Methohexital—Nausea—Dasatinib—hematologic cancer	0.00107	0.00107	CcSEcCtD
Methohexital—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.00107	0.00107	CcSEcCtD
Methohexital—Anaphylactic shock—Irinotecan—hematologic cancer	0.00107	0.00107	CcSEcCtD
Methohexital—Dyspnoea—Thalidomide—hematologic cancer	0.00107	0.00107	CcSEcCtD
Methohexital—Nausea—Fludarabine—hematologic cancer	0.00107	0.00107	CcSEcCtD
Methohexital—Hypotension—Alitretinoin—hematologic cancer	0.00107	0.00107	CcSEcCtD
Methohexital—Gastrointestinal pain—Vinorelbine—hematologic cancer	0.00106	0.00106	CcSEcCtD
Methohexital—Vomiting—Nilotinib—hematologic cancer	0.00106	0.00106	CcSEcCtD
Methohexital—Urticaria—Bortezomib—hematologic cancer	0.00106	0.00106	CcSEcCtD
Methohexital—Vomiting—Imatinib—hematologic cancer	0.00105	0.00106	CcSEcCtD
Methohexital—Hypotension—Ifosfamide—hematologic cancer	0.00105	0.00106	CcSEcCtD
Methohexital—Shock—Irinotecan—hematologic cancer	0.00105	0.00106	CcSEcCtD
Methohexital—Shock—Mitoxantrone—hematologic cancer	0.00105	0.00106	CcSEcCtD
Methohexital—Pruritus—Melphalan—hematologic cancer	0.00105	0.00105	CcSEcCtD
Methohexital—Abdominal pain—Bortezomib—hematologic cancer	0.00105	0.00105	CcSEcCtD
Methohexital—Urticaria—Bleomycin—hematologic cancer	0.00105	0.00105	CcSEcCtD
Methohexital—Tachycardia—Mitoxantrone—hematologic cancer	0.00104	0.00105	CcSEcCtD
Methohexital—Headache—Nilotinib—hematologic cancer	0.00104	0.00105	CcSEcCtD
Methohexital—Anaphylactic shock—Gemcitabine—hematologic cancer	0.00104	0.00104	CcSEcCtD
Methohexital—Headache—Imatinib—hematologic cancer	0.00104	0.00104	CcSEcCtD
Methohexital—Vomiting—Cladribine—hematologic cancer	0.00104	0.00104	CcSEcCtD
Methohexital—Convulsion—Cisplatin—hematologic cancer	0.00103	0.00103	CcSEcCtD
Methohexital—Urticaria—Vinorelbine—hematologic cancer	0.00103	0.00103	CcSEcCtD
Methohexital—Hypotension—Vincristine—hematologic cancer	0.00103	0.00103	CcSEcCtD
Methohexital—Dyspnoea—Carmustine—hematologic cancer	0.00103	0.00103	CcSEcCtD
Methohexital—Abdominal pain—Vinorelbine—hematologic cancer	0.00103	0.00103	CcSEcCtD
Methohexital—Pruritus—Lenalidomide—hematologic cancer	0.00102	0.00102	CcSEcCtD
Methohexital—Headache—Cladribine—hematologic cancer	0.00102	0.00102	CcSEcCtD
Methohexital—Dyspnoea—Alitretinoin—hematologic cancer	0.00102	0.00102	CcSEcCtD
Methohexital—Gastrointestinal pain—Thiotepa—hematologic cancer	0.00101	0.00102	CcSEcCtD
Methohexital—Nausea—Chlorambucil—hematologic cancer	0.00101	0.00101	CcSEcCtD
Methohexital—Anxiety—Cisplatin—hematologic cancer	0.00101	0.00101	CcSEcCtD
Methohexital—Dyspnoea—Ifosfamide—hematologic cancer	0.001	0.00101	CcSEcCtD
Methohexital—Liver function test abnormal—Methotrexate—hematologic cancer	0.001	0.001	CcSEcCtD
Methohexital—Hypotension—Irinotecan—hematologic cancer	0.001	0.001	CcSEcCtD
Methohexital—Hypotension—Mitoxantrone—hematologic cancer	0.001	0.001	CcSEcCtD
Methohexital—Vomiting—Vinblastine—hematologic cancer	0.000993	0.000995	CcSEcCtD
Methohexital—Nausea—Nilotinib—hematologic cancer	0.00099	0.000992	CcSEcCtD
Methohexital—Erythema—Triamcinolone—hematologic cancer	0.000989	0.000991	CcSEcCtD
Methohexital—Urticaria—Thiotepa—hematologic cancer	0.000985	0.000987	CcSEcCtD
Methohexital—Nausea—Imatinib—hematologic cancer	0.000984	0.000986	CcSEcCtD
Methohexital—Gastrointestinal pain—Thalidomide—hematologic cancer	0.00098	0.000982	CcSEcCtD
Methohexital—Abdominal pain—Thiotepa—hematologic cancer	0.00098	0.000982	CcSEcCtD
Methohexital—Headache—Vinblastine—hematologic cancer	0.000978	0.00098	CcSEcCtD
Methohexital—Hypotension—Gemcitabine—hematologic cancer	0.000974	0.000976	CcSEcCtD
Methohexital—Anaphylactic shock—Cisplatin—hematologic cancer	0.000972	0.000974	CcSEcCtD
Methohexital—Nausea—Cladribine—hematologic cancer	0.000967	0.000969	CcSEcCtD
Methohexital—Dyspnoea—Mitoxantrone—hematologic cancer	0.000954	0.000956	CcSEcCtD
Methohexital—Dyspnoea—Irinotecan—hematologic cancer	0.000954	0.000956	CcSEcCtD
Methohexital—Urticaria—Thalidomide—hematologic cancer	0.000952	0.000954	CcSEcCtD
Methohexital—Tachycardia—Cisplatin—hematologic cancer	0.000948	0.00095	CcSEcCtD
Methohexital—Abdominal pain—Thalidomide—hematologic cancer	0.000948	0.00095	CcSEcCtD
Methohexital—Convulsion—Etoposide—hematologic cancer	0.000945	0.000947	CcSEcCtD
Methohexital—Vomiting—Melphalan—hematologic cancer	0.000944	0.000946	CcSEcCtD
Methohexital—Gastrointestinal pain—Carmustine—hematologic cancer	0.000941	0.000943	CcSEcCtD
Methohexital—Pruritus—Bortezomib—hematologic cancer	0.00094	0.000942	CcSEcCtD
Methohexital—Liver function test abnormal—Epirubicin—hematologic cancer	0.000937	0.000939	CcSEcCtD
Methohexital—Pruritus—Bleomycin—hematologic cancer	0.000933	0.000935	CcSEcCtD
Methohexital—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.000933	0.000935	CcSEcCtD
Methohexital—Convulsion—Prednisolone—hematologic cancer	0.000932	0.000934	CcSEcCtD
Methohexital—Dyspnoea—Gemcitabine—hematologic cancer	0.000929	0.000931	CcSEcCtD
Methohexital—Nausea—Vinblastine—hematologic cancer	0.000928	0.00093	CcSEcCtD
Methohexital—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000922	0.000924	CcSEcCtD
Methohexital—Vomiting—Lenalidomide—hematologic cancer	0.000918	0.00092	CcSEcCtD
Methohexital—Pruritus—Vinorelbine—hematologic cancer	0.000918	0.00092	CcSEcCtD
Methohexital—Abdominal pain—Carmustine—hematologic cancer	0.00091	0.000912	CcSEcCtD
Methohexital—Hypotension—Cisplatin—hematologic cancer	0.000908	0.00091	CcSEcCtD
Methohexital—Urticaria—Alitretinoin—hematologic cancer	0.000906	0.000908	CcSEcCtD
Methohexital—Vomiting—Hydroxyurea—hematologic cancer	0.000905	0.000907	CcSEcCtD
Methohexital—Headache—Lenalidomide—hematologic cancer	0.000905	0.000907	CcSEcCtD
Methohexital—Abdominal pain—Alitretinoin—hematologic cancer	0.000902	0.000903	CcSEcCtD
Methohexital—Gastrointestinal pain—Vincristine—hematologic cancer	0.000899	0.000901	CcSEcCtD
Methohexital—Erythema—Dexamethasone—hematologic cancer	0.000898	0.0009	CcSEcCtD
Methohexital—Erythema—Betamethasone—hematologic cancer	0.000898	0.0009	CcSEcCtD
Methohexital—Urticaria—Ifosfamide—hematologic cancer	0.000895	0.000897	CcSEcCtD
Methohexital—Headache—Hydroxyurea—hematologic cancer	0.000892	0.000894	CcSEcCtD
Methohexital—Abdominal pain—Ifosfamide—hematologic cancer	0.000891	0.000893	CcSEcCtD
Methohexital—Anaphylactic shock—Etoposide—hematologic cancer	0.00089	0.000892	CcSEcCtD
Methohexital—Nausea—Melphalan—hematologic cancer	0.000882	0.000884	CcSEcCtD
Methohexital—Anaphylactic shock—Prednisolone—hematologic cancer	0.000878	0.00088	CcSEcCtD
Methohexital—Pruritus—Thiotepa—hematologic cancer	0.000877	0.000879	CcSEcCtD
Methohexital—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000875	0.000877	CcSEcCtD
Methohexital—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000875	0.000877	CcSEcCtD
Methohexital—Tachycardia—Etoposide—hematologic cancer	0.000869	0.000871	CcSEcCtD
Methohexital—Abdominal pain—Vincristine—hematologic cancer	0.000869	0.000871	CcSEcCtD
Methohexital—Liver function test abnormal—Doxorubicin—hematologic cancer	0.000867	0.000869	CcSEcCtD
Methohexital—Dyspnoea—Cisplatin—hematologic cancer	0.000866	0.000868	CcSEcCtD
Methohexital—Shock—Prednisolone—hematologic cancer	0.000864	0.000866	CcSEcCtD
Methohexital—Nausea—Lenalidomide—hematologic cancer	0.000858	0.00086	CcSEcCtD
Methohexital—Convulsion—Triamcinolone—hematologic cancer	0.000857	0.000859	CcSEcCtD
Methohexital—Tachycardia—Prednisolone—hematologic cancer	0.000857	0.000859	CcSEcCtD
Methohexital—Urticaria—Mitoxantrone—hematologic cancer	0.00085	0.000852	CcSEcCtD
Methohexital—Pruritus—Thalidomide—hematologic cancer	0.000848	0.00085	CcSEcCtD
Methohexital—Abdominal pain—Mitoxantrone—hematologic cancer	0.000846	0.000848	CcSEcCtD
Methohexital—Abdominal pain—Irinotecan—hematologic cancer	0.000846	0.000848	CcSEcCtD
Methohexital—Nausea—Hydroxyurea—hematologic cancer	0.000846	0.000848	CcSEcCtD
Methohexital—Vomiting—Bortezomib—hematologic cancer	0.000845	0.000847	CcSEcCtD
Methohexital—Vomiting—Bleomycin—hematologic cancer	0.000839	0.00084	CcSEcCtD
Methohexital—Headache—Bortezomib—hematologic cancer	0.000833	0.000834	CcSEcCtD
Methohexital—Hypotension—Etoposide—hematologic cancer	0.000832	0.000834	CcSEcCtD
Methohexital—Vomiting—Vinorelbine—hematologic cancer	0.000825	0.000827	CcSEcCtD
Methohexital—Headache—Vinorelbine—hematologic cancer	0.000813	0.000815	CcSEcCtD
Methohexital—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000807	0.000809	CcSEcCtD
Methohexital—Pruritus—Alitretinoin—hematologic cancer	0.000807	0.000809	CcSEcCtD
Methohexital—Pruritus—Ifosfamide—hematologic cancer	0.000797	0.000799	CcSEcCtD
Methohexital—Shock—Triamcinolone—hematologic cancer	0.000794	0.000796	CcSEcCtD
Methohexital—Dyspnoea—Etoposide—hematologic cancer	0.000794	0.000795	CcSEcCtD
Methohexital—Nausea—Bortezomib—hematologic cancer	0.000789	0.000791	CcSEcCtD
Methohexital—Tachycardia—Triamcinolone—hematologic cancer	0.000788	0.00079	CcSEcCtD
Methohexital—Vomiting—Thiotepa—hematologic cancer	0.000788	0.00079	CcSEcCtD
Methohexital—Nausea—Bleomycin—hematologic cancer	0.000783	0.000785	CcSEcCtD
Methohexital—Erythema—Prednisone—hematologic cancer	0.000782	0.000783	CcSEcCtD
Methohexital—Convulsion—Betamethasone—hematologic cancer	0.000778	0.000779	CcSEcCtD
Methohexital—Convulsion—Dexamethasone—hematologic cancer	0.000778	0.000779	CcSEcCtD
Methohexital—Headache—Thiotepa—hematologic cancer	0.000776	0.000778	CcSEcCtD
Methohexital—Nausea—Vinorelbine—hematologic cancer	0.000771	0.000772	CcSEcCtD
Methohexital—Vomiting—Thalidomide—hematologic cancer	0.000762	0.000764	CcSEcCtD
Methohexital—Anxiety—Dexamethasone—hematologic cancer	0.000762	0.000763	CcSEcCtD
Methohexital—Anxiety—Betamethasone—hematologic cancer	0.000762	0.000763	CcSEcCtD
Methohexital—Headache—Thalidomide—hematologic cancer	0.000751	0.000753	CcSEcCtD
Methohexital—Pruritus—Gemcitabine—hematologic cancer	0.000738	0.000739	CcSEcCtD
Methohexital—Nausea—Thiotepa—hematologic cancer	0.000736	0.000738	CcSEcCtD
Methohexital—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000733	0.000734	CcSEcCtD
Methohexital—Anaphylactic shock—Betamethasone—hematologic cancer	0.000733	0.000734	CcSEcCtD
Methohexital—Vomiting—Carmustine—hematologic cancer	0.000732	0.000734	CcSEcCtD
Methohexital—Gastrointestinal pain—Etoposide—hematologic cancer	0.000728	0.00073	CcSEcCtD
Methohexital—Vomiting—Alitretinoin—hematologic cancer	0.000725	0.000727	CcSEcCtD
Methohexital—Headache—Carmustine—hematologic cancer	0.000721	0.000723	CcSEcCtD
Methohexital—Shock—Dexamethasone—hematologic cancer	0.000721	0.000722	CcSEcCtD
Methohexital—Shock—Betamethasone—hematologic cancer	0.000721	0.000722	CcSEcCtD
Methohexital—Dyspnoea—Triamcinolone—hematologic cancer	0.00072	0.000721	CcSEcCtD
Methohexital—Agitation—Prednisone—hematologic cancer	0.000718	0.00072	CcSEcCtD
Methohexital—Vomiting—Ifosfamide—hematologic cancer	0.000717	0.000718	CcSEcCtD
Methohexital—Tachycardia—Dexamethasone—hematologic cancer	0.000715	0.000717	CcSEcCtD
Methohexital—Tachycardia—Betamethasone—hematologic cancer	0.000715	0.000717	CcSEcCtD
Methohexital—Headache—Alitretinoin—hematologic cancer	0.000714	0.000716	CcSEcCtD
Methohexital—Nausea—Thalidomide—hematologic cancer	0.000712	0.000714	CcSEcCtD
Methohexital—Urticaria—Etoposide—hematologic cancer	0.000707	0.000709	CcSEcCtD
Methohexital—Rhinitis—Epirubicin—hematologic cancer	0.000704	0.000706	CcSEcCtD
Methohexital—Abdominal pain—Etoposide—hematologic cancer	0.000704	0.000705	CcSEcCtD
Methohexital—Vomiting—Vincristine—hematologic cancer	0.000699	0.0007	CcSEcCtD
Methohexital—Urticaria—Prednisolone—hematologic cancer	0.000698	0.000699	CcSEcCtD
Methohexital—Headache—Vincristine—hematologic cancer	0.000688	0.00069	CcSEcCtD
Methohexital—Hypotension—Betamethasone—hematologic cancer	0.000685	0.000686	CcSEcCtD
Methohexital—Hypotension—Dexamethasone—hematologic cancer	0.000685	0.000686	CcSEcCtD
Methohexital—Nausea—Carmustine—hematologic cancer	0.000684	0.000685	CcSEcCtD
Methohexital—Vomiting—Mitoxantrone—hematologic cancer	0.000681	0.000682	CcSEcCtD
Methohexital—Vomiting—Irinotecan—hematologic cancer	0.000681	0.000682	CcSEcCtD
Methohexital—Nausea—Alitretinoin—hematologic cancer	0.000677	0.000679	CcSEcCtD
Methohexital—Convulsion—Prednisone—hematologic cancer	0.000677	0.000679	CcSEcCtD
Methohexital—Headache—Mitoxantrone—hematologic cancer	0.000671	0.000672	CcSEcCtD
Methohexital—Headache—Irinotecan—hematologic cancer	0.000671	0.000672	CcSEcCtD
Methohexital—Nausea—Ifosfamide—hematologic cancer	0.00067	0.000671	CcSEcCtD
Methohexital—Anxiety—Prednisone—hematologic cancer	0.000663	0.000665	CcSEcCtD
Methohexital—Vomiting—Gemcitabine—hematologic cancer	0.000663	0.000664	CcSEcCtD
Methohexital—Erythema—Methotrexate—hematologic cancer	0.000653	0.000655	CcSEcCtD
Methohexital—Headache—Gemcitabine—hematologic cancer	0.000653	0.000655	CcSEcCtD
Methohexital—Nausea—Vincristine—hematologic cancer	0.000653	0.000654	CcSEcCtD
Methohexital—Rhinitis—Doxorubicin—hematologic cancer	0.000652	0.000653	CcSEcCtD
Methohexital—Urticaria—Triamcinolone—hematologic cancer	0.000641	0.000643	CcSEcCtD
Methohexital—Anaphylactic shock—Prednisone—hematologic cancer	0.000638	0.000639	CcSEcCtD
Methohexital—Nausea—Irinotecan—hematologic cancer	0.000636	0.000637	CcSEcCtD
Methohexital—Nausea—Mitoxantrone—hematologic cancer	0.000636	0.000637	CcSEcCtD
Methohexital—Pruritus—Etoposide—hematologic cancer	0.00063	0.000631	CcSEcCtD
Methohexital—Shock—Prednisone—hematologic cancer	0.000628	0.000629	CcSEcCtD
Methohexital—Tachycardia—Prednisone—hematologic cancer	0.000623	0.000624	CcSEcCtD
Methohexital—Nausea—Gemcitabine—hematologic cancer	0.000619	0.000621	CcSEcCtD
Methohexital—Vomiting—Cisplatin—hematologic cancer	0.000618	0.000619	CcSEcCtD
Methohexital—Erythema—Epirubicin—hematologic cancer	0.000611	0.000613	CcSEcCtD
Methohexital—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000599	0.0006	CcSEcCtD
Methohexital—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000599	0.0006	CcSEcCtD
Methohexital—Urticaria—Betamethasone—hematologic cancer	0.000582	0.000583	CcSEcCtD
Methohexital—Urticaria—Dexamethasone—hematologic cancer	0.000582	0.000583	CcSEcCtD
Methohexital—Abdominal pain—Betamethasone—hematologic cancer	0.000579	0.00058	CcSEcCtD
Methohexital—Abdominal pain—Dexamethasone—hematologic cancer	0.000579	0.00058	CcSEcCtD
Methohexital—Nausea—Cisplatin—hematologic cancer	0.000577	0.000578	CcSEcCtD
Methohexital—Pruritus—Triamcinolone—hematologic cancer	0.000571	0.000573	CcSEcCtD
Methohexital—Convulsion—Methotrexate—hematologic cancer	0.000566	0.000567	CcSEcCtD
Methohexital—Vomiting—Etoposide—hematologic cancer	0.000566	0.000567	CcSEcCtD
Methohexital—Erythema—Doxorubicin—hematologic cancer	0.000566	0.000567	CcSEcCtD
Methohexital—Agitation—Epirubicin—hematologic cancer	0.000562	0.000563	CcSEcCtD
Methohexital—Headache—Etoposide—hematologic cancer	0.000558	0.000559	CcSEcCtD
Methohexital—Headache—Prednisolone—hematologic cancer	0.00055	0.000551	CcSEcCtD
Methohexital—Anaphylactic shock—Methotrexate—hematologic cancer	0.000533	0.000534	CcSEcCtD
Methohexital—Convulsion—Epirubicin—hematologic cancer	0.00053	0.000531	CcSEcCtD
Methohexital—Nausea—Etoposide—hematologic cancer	0.000529	0.00053	CcSEcCtD
Methohexital—Gastrointestinal pain—Prednisone—hematologic cancer	0.000522	0.000523	CcSEcCtD
Methohexital—Nausea—Prednisolone—hematologic cancer	0.000522	0.000523	CcSEcCtD
Methohexital—Agitation—Doxorubicin—hematologic cancer	0.00052	0.000521	CcSEcCtD
Methohexital—Anxiety—Epirubicin—hematologic cancer	0.000519	0.00052	CcSEcCtD
Methohexital—Pruritus—Betamethasone—hematologic cancer	0.000518	0.000519	CcSEcCtD
Methohexital—Pruritus—Dexamethasone—hematologic cancer	0.000518	0.000519	CcSEcCtD
Methohexital—Vomiting—Triamcinolone—hematologic cancer	0.000513	0.000514	CcSEcCtD
Methohexital—Urticaria—Prednisone—hematologic cancer	0.000507	0.000508	CcSEcCtD
Methohexital—Headache—Triamcinolone—hematologic cancer	0.000506	0.000507	CcSEcCtD
Methohexital—Abdominal pain—Prednisone—hematologic cancer	0.000504	0.000505	CcSEcCtD
Methohexital—Anaphylactic shock—Epirubicin—hematologic cancer	0.000499	0.0005	CcSEcCtD
Methohexital—Hypotension—Methotrexate—hematologic cancer	0.000498	0.000499	CcSEcCtD
Methohexital—Shock—Epirubicin—hematologic cancer	0.000491	0.000492	CcSEcCtD
Methohexital—Convulsion—Doxorubicin—hematologic cancer	0.00049	0.000491	CcSEcCtD
Methohexital—Tachycardia—Epirubicin—hematologic cancer	0.000487	0.000488	CcSEcCtD
Methohexital—Anxiety—Doxorubicin—hematologic cancer	0.00048	0.000481	CcSEcCtD
Methohexital—Nausea—Triamcinolone—hematologic cancer	0.00048	0.000481	CcSEcCtD
Methohexital—Dyspnoea—Methotrexate—hematologic cancer	0.000475	0.000476	CcSEcCtD
Methohexital—Hypotension—Epirubicin—hematologic cancer	0.000466	0.000467	CcSEcCtD
Methohexital—Vomiting—Dexamethasone—hematologic cancer	0.000466	0.000467	CcSEcCtD
Methohexital—Vomiting—Betamethasone—hematologic cancer	0.000466	0.000467	CcSEcCtD
Methohexital—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000462	0.000463	CcSEcCtD
Methohexital—Headache—Dexamethasone—hematologic cancer	0.000459	0.00046	CcSEcCtD
Methohexital—Headache—Betamethasone—hematologic cancer	0.000459	0.00046	CcSEcCtD
Methohexital—Shock—Doxorubicin—hematologic cancer	0.000454	0.000455	CcSEcCtD
Methohexital—Pruritus—Prednisone—hematologic cancer	0.000451	0.000452	CcSEcCtD
Methohexital—Tachycardia—Doxorubicin—hematologic cancer	0.000451	0.000452	CcSEcCtD
Methohexital—Dyspnoea—Epirubicin—hematologic cancer	0.000445	0.000446	CcSEcCtD
Methohexital—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000436	0.000437	CcSEcCtD
Methohexital—Nausea—Betamethasone—hematologic cancer	0.000435	0.000436	CcSEcCtD
Methohexital—Nausea—Dexamethasone—hematologic cancer	0.000435	0.000436	CcSEcCtD
Methohexital—Hypotension—Doxorubicin—hematologic cancer	0.000431	0.000432	CcSEcCtD
Methohexital—Urticaria—Methotrexate—hematologic cancer	0.000424	0.000425	CcSEcCtD
Methohexital—Abdominal pain—Methotrexate—hematologic cancer	0.000422	0.000422	CcSEcCtD
Methohexital—Dyspnoea—Doxorubicin—hematologic cancer	0.000412	0.000413	CcSEcCtD
Methohexital—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000408	0.000409	CcSEcCtD
Methohexital—Vomiting—Prednisone—hematologic cancer	0.000406	0.000407	CcSEcCtD
Methohexital—Headache—Prednisone—hematologic cancer	0.0004	0.000401	CcSEcCtD
Methohexital—Urticaria—Epirubicin—hematologic cancer	0.000396	0.000397	CcSEcCtD
Methohexital—Abdominal pain—Epirubicin—hematologic cancer	0.000394	0.000395	CcSEcCtD
Methohexital—Nausea—Prednisone—hematologic cancer	0.000379	0.00038	CcSEcCtD
Methohexital—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000378	0.000378	CcSEcCtD
Methohexital—Pruritus—Methotrexate—hematologic cancer	0.000377	0.000378	CcSEcCtD
Methohexital—Urticaria—Doxorubicin—hematologic cancer	0.000367	0.000368	CcSEcCtD
Methohexital—Abdominal pain—Doxorubicin—hematologic cancer	0.000365	0.000366	CcSEcCtD
Methohexital—Pruritus—Epirubicin—hematologic cancer	0.000353	0.000354	CcSEcCtD
Methohexital—Vomiting—Methotrexate—hematologic cancer	0.000339	0.00034	CcSEcCtD
Methohexital—Headache—Methotrexate—hematologic cancer	0.000334	0.000335	CcSEcCtD
Methohexital—Pruritus—Doxorubicin—hematologic cancer	0.000327	0.000327	CcSEcCtD
Methohexital—Vomiting—Epirubicin—hematologic cancer	0.000317	0.000318	CcSEcCtD
Methohexital—Nausea—Methotrexate—hematologic cancer	0.000317	0.000317	CcSEcCtD
Methohexital—Headache—Epirubicin—hematologic cancer	0.000313	0.000313	CcSEcCtD
Methohexital—Nausea—Epirubicin—hematologic cancer	0.000296	0.000297	CcSEcCtD
Methohexital—Vomiting—Doxorubicin—hematologic cancer	0.000294	0.000294	CcSEcCtD
Methohexital—Headache—Doxorubicin—hematologic cancer	0.000289	0.00029	CcSEcCtD
Methohexital—Nausea—Doxorubicin—hematologic cancer	0.000274	0.000275	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	4.75e-05	0.0226	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—S100A10—hematologic cancer	4.02e-05	0.0192	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—S100A10—hematologic cancer	3.95e-05	0.0188	CbGpPWpGaD
Methohexital—GABRB3—GABA receptor activation—ADCY7—hematologic cancer	3.46e-05	0.0165	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—FXYD6—hematologic cancer	3.46e-05	0.0165	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—S100A10—hematologic cancer	3.45e-05	0.0164	CbGpPWpGaD
Methohexital—GABRG2—GABA receptor activation—ADCY7—hematologic cancer	3.4e-05	0.0162	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—FXYD6—hematologic cancer	3.4e-05	0.0162	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	3.29e-05	0.0157	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—ANXA2—hematologic cancer	3.05e-05	0.0145	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—ANXA2—hematologic cancer	2.99e-05	0.0143	CbGpPWpGaD
Methohexital—GABRA1—GABA receptor activation—ADCY7—hematologic cancer	2.97e-05	0.0142	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—FXYD6—hematologic cancer	2.97e-05	0.0141	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—TUBB2A—hematologic cancer	2.74e-05	0.0131	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—TUBB2A—hematologic cancer	2.69e-05	0.0128	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—ANXA2—hematologic cancer	2.61e-05	0.0125	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	2.6e-05	0.0124	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—ATP1B1—hematologic cancer	2.46e-05	0.0117	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP1B1—hematologic cancer	2.42e-05	0.0115	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	2.4e-05	0.0114	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—TUBB2A—hematologic cancer	2.35e-05	0.0112	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—TIAM1—hematologic cancer	2.15e-05	0.0102	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—ATP4A—hematologic cancer	2.14e-05	0.0102	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—SGK1—hematologic cancer	2.14e-05	0.0102	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—RET—hematologic cancer	2.12e-05	0.0101	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—ATP1B1—hematologic cancer	2.11e-05	0.0101	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP4A—hematologic cancer	2.1e-05	0.01	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—SGK1—hematologic cancer	2.1e-05	0.01	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—ATP4A—hematologic cancer	1.83e-05	0.00874	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—SGK1—hematologic cancer	1.83e-05	0.00874	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—STAT5B—hematologic cancer	1.6e-05	0.00763	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—ALPL—hematologic cancer	1.6e-05	0.00763	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY7—hematologic cancer	1.59e-05	0.00758	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY7—hematologic cancer	1.56e-05	0.00744	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—NCAM1—hematologic cancer	1.51e-05	0.00721	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	1.49e-05	0.00712	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—CYCS—hematologic cancer	1.47e-05	0.007	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	1.45e-05	0.0069	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—CYCS—hematologic cancer	1.44e-05	0.00687	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	1.43e-05	0.00683	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—EIF4EBP1—hematologic cancer	1.42e-05	0.00678	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—hematologic cancer	1.41e-05	0.00674	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—hematologic cancer	1.39e-05	0.00662	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—MYB—hematologic cancer	1.38e-05	0.00657	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY7—hematologic cancer	1.36e-05	0.00651	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	1.3e-05	0.00622	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—AQP9—hematologic cancer	1.29e-05	0.00617	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	1.28e-05	0.00611	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—AQP9—hematologic cancer	1.27e-05	0.00606	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—CYCS—hematologic cancer	1.26e-05	0.006	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—hematologic cancer	1.21e-05	0.00579	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—FXYD6—hematologic cancer	1.2e-05	0.00574	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—ADCY7—hematologic cancer	1.2e-05	0.0057	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	1.18e-05	0.00563	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL13—hematologic cancer	1.18e-05	0.00562	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—ADCY7—hematologic cancer	1.17e-05	0.0056	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	1.12e-05	0.00534	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—AQP9—hematologic cancer	1.11e-05	0.0053	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—STAT1—hematologic cancer	1.08e-05	0.00517	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	1.06e-05	0.00507	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	1.06e-05	0.00507	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	1.04e-05	0.00498	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	1.03e-05	0.00492	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—ADCY7—hematologic cancer	1.03e-05	0.00489	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—GRB2—hematologic cancer	1.01e-05	0.00483	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—SLC22A1—hematologic cancer	1e-05	0.00476	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—SLC22A1—hematologic cancer	9.82e-06	0.00468	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—S100A10—hematologic cancer	9.81e-06	0.00468	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—STAT5A—hematologic cancer	9.75e-06	0.00465	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—S100A10—hematologic cancer	9.63e-06	0.00459	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—ADCY7—hematologic cancer	9.16e-06	0.00437	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	9.13e-06	0.00435	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	9.12e-06	0.00435	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—ADCY7—hematologic cancer	8.99e-06	0.00429	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	8.96e-06	0.00427	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	8.94e-06	0.00426	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	8.78e-06	0.00419	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—SLC22A1—hematologic cancer	8.58e-06	0.00409	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	8.57e-06	0.00409	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—AR—hematologic cancer	8.44e-06	0.00402	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	8.42e-06	0.00401	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—S100A10—hematologic cancer	8.42e-06	0.00401	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—CREBBP—hematologic cancer	8.18e-06	0.0039	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—CAMK2D—hematologic cancer	8.15e-06	0.00388	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	8.13e-06	0.00387	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—CREBBP—hematologic cancer	8.04e-06	0.00383	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—CAMK2D—hematologic cancer	8e-06	0.00381	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	7.98e-06	0.0038	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—ADCY7—hematologic cancer	7.86e-06	0.00375	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	7.83e-06	0.00373	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—TSC2—hematologic cancer	7.7e-06	0.00367	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—hematologic cancer	7.68e-06	0.00366	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	7.43e-06	0.00354	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	7.43e-06	0.00354	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SGK1—hematologic cancer	7.43e-06	0.00354	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HES1—hematologic cancer	7.42e-06	0.00354	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL10—hematologic cancer	7.38e-06	0.00352	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	7.36e-06	0.00351	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MAPK14—hematologic cancer	7.34e-06	0.0035	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	7.3e-06	0.00348	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	7.3e-06	0.00348	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SGK1—hematologic cancer	7.3e-06	0.00348	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—BAD—hematologic cancer	7.03e-06	0.00335	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—NFKBIA—hematologic cancer	7.03e-06	0.00335	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—CREBBP—hematologic cancer	7.02e-06	0.00335	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—CAMK2D—hematologic cancer	6.99e-06	0.00333	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	6.98e-06	0.00333	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	6.83e-06	0.00325	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—PRKCG—hematologic cancer	6.72e-06	0.00321	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	6.69e-06	0.00319	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—PTPN11—hematologic cancer	6.68e-06	0.00319	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	6.62e-06	0.00316	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	6.6e-06	0.00315	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	6.57e-06	0.00313	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	6.54e-06	0.00312	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	6.5e-06	0.0031	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—FOS—hematologic cancer	6.49e-06	0.00309	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—CREB1—hematologic cancer	6.48e-06	0.00309	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	6.42e-06	0.00306	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	6.38e-06	0.00304	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	6.38e-06	0.00304	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SGK1—hematologic cancer	6.38e-06	0.00304	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MAP2K1—hematologic cancer	6.02e-06	0.00287	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.88e-06	0.0028	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	5.77e-06	0.00275	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.77e-06	0.00275	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	5.75e-06	0.00274	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	5.69e-06	0.00271	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—PIK3R1—hematologic cancer	5.65e-06	0.00269	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	5.61e-06	0.00268	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—JAK2—hematologic cancer	5.49e-06	0.00262	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	5.48e-06	0.00261	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	5.38e-06	0.00257	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	5.37e-06	0.00256	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	5.28e-06	0.00252	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	5.21e-06	0.00249	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MTOR—hematologic cancer	5.21e-06	0.00249	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—PRKCG—hematologic cancer	5.15e-06	0.00246	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	5.09e-06	0.00242	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	5.08e-06	0.00242	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.07e-06	0.00242	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—PRKCG—hematologic cancer	5.06e-06	0.00241	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.04e-06	0.0024	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.98e-06	0.00237	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—CREB1—hematologic cancer	4.98e-06	0.00237	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.92e-06	0.00235	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—BRAF—hematologic cancer	4.92e-06	0.00234	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—CREB1—hematologic cancer	4.89e-06	0.00233	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.89e-06	0.00233	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.84e-06	0.0023	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—BRAF—hematologic cancer	4.83e-06	0.0023	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.8e-06	0.00229	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—CASP3—hematologic cancer	4.8e-06	0.00229	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.79e-06	0.00228	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.7e-06	0.00224	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	4.7e-06	0.00224	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—JUN—hematologic cancer	4.66e-06	0.00222	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.61e-06	0.0022	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—PRKCG—hematologic cancer	4.42e-06	0.00211	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MAPK8—hematologic cancer	4.41e-06	0.0021	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.35e-06	0.00208	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—CREB1—hematologic cancer	4.27e-06	0.00204	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.27e-06	0.00204	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.23e-06	0.00201	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—BRAF—hematologic cancer	4.22e-06	0.00201	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.2e-06	0.002	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.19e-06	0.002	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—SRC—hematologic cancer	4.18e-06	0.00199	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.12e-06	0.00196	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.11e-06	0.00196	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.05e-06	0.00193	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—STAT3—hematologic cancer	4.03e-06	0.00192	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	3.87e-06	0.00184	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	3.86e-06	0.00184	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MAPK3—hematologic cancer	3.85e-06	0.00183	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—CREB1—hematologic cancer	3.82e-06	0.00182	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—BRAF—hematologic cancer	3.77e-06	0.0018	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—JUN—hematologic cancer	3.75e-06	0.00179	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—CREB1—hematologic cancer	3.75e-06	0.00179	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—BRAF—hematologic cancer	3.7e-06	0.00176	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.66e-06	0.00175	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.58e-06	0.00171	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—MDM2—hematologic cancer	3.54e-06	0.00169	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.52e-06	0.00168	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—EP300—hematologic cancer	3.46e-06	0.00165	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	3.28e-06	0.00156	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—CREB1—hematologic cancer	3.27e-06	0.00156	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—BRAF—hematologic cancer	3.23e-06	0.00154	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—MDM2—hematologic cancer	3.16e-06	0.0015	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—MDM2—hematologic cancer	3.1e-06	0.00148	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.08e-06	0.00147	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.01e-06	0.00143	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.99e-06	0.00143	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.95e-06	0.00141	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—HRAS—hematologic cancer	2.94e-06	0.0014	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.94e-06	0.0014	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	2.81e-06	0.00134	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—MDM2—hematologic cancer	2.71e-06	0.00129	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	2.6e-06	0.00124	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.58e-06	0.00123	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.57e-06	0.00122	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	2.27e-06	0.00108	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.26e-06	0.00108	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.22e-06	0.00106	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2e-06	0.000952	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.96e-06	0.000935	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.94e-06	0.000925	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.87e-06	0.000891	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.84e-06	0.000875	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—HRAS—hematologic cancer	1.73e-06	0.000826	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.72e-06	0.000817	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—HRAS—hematologic cancer	1.7e-06	0.000811	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.61e-06	0.000765	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—HRAS—hematologic cancer	1.49e-06	0.000709	CbGpPWpGaD
